clinical trial · NCT07675265
Observational, Non-interventional Biomarker and Endotyping Study
Prenosis, Inc.·—·not yet recruiting·n = 1,200
ARDS (Acute Respiratory Distress Syndrome)
brief summary
The goal of this observational study is to establish a centralized ARDS biorepository of longitudinal biospecimens and harmonized clinical data, develop unsupervised, therapy-agnostic endotyping algorithms, and develop unsupervised, therapy-specific treatment-prediction algorithms over a 24 month period.
started
Jul 1, 2026
primary completion
Dec 1, 2028
completion
Mar 1, 2029
last updated
Jun 30, 2026
official title
Observational Biomarker Study for the Evaluation of Response and Validation of Endotypes in Acute Respiratory Distress Syndrome
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol